Samenvatting
De kern
Inleiding
Vroegdetectie
Voorspeller | Punten |
---|---|
Ischemische hartziekte in de VG | 2 |
BMI > 30 kg/m2 | 4 |
Lateraal verplaatste apex | 4 |
Hartritme > 90 slagen/minuut | 1 |
NT-proBNP > 14,75 pmol/L (125 pg/ml) | 9 |
Abnormaal elektrocardiogram | 5 |
Perifeer oedeem | 4 |
Leeftijd > 75 jaar | 3 |
Systolische cardiale souffle | 3 |
Vroege behandeling
Dilemma’s rondom vroegdetectie en -behandeling
Conclusie
Literatuur
- 1.↲Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 2007;93:1137-46.
- 2.↲Van Riet EES, Hoes AW, Wagenaar KP, Limburg A, Landman MAJ, Rutten F. Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review. Eur J Heart Fail 2016;18:242-52.
- 3.↲Schocken DD, Benjamin EJ, Fonarow GC, Krumholz HM, Levy D, Mensah GA, et al. Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 2008;117:2544-65.
- 4.↲↲McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012;14:803-69.
- 5.↲Van Riet EES, Hoes AW, Limburg A, Landman MAJ, Van der Hoeven H, Rutten FH. Niet-herkend hartfalen bij ouderen met kortademigheid. Huisarts Wet 2015;58:354-7.
- 6.↲Rutten FH, Cramer MJ, Grobbee DE, Sachs AP, Kirkels JH, Lammers JW, Hoes AW. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 2005;26:1887-94.
- 7.↲Anguita Sanchez M, Crespo Leiro MG, De Teresa Galvan E, Jimenez Navarro M, Alonso-Pulpon L, Muniz Garcia J. Prevalence of heart failure in the Spanish general population aged over 45 years. The PRICE Study. Rev Esp Cardiol 2008;61:1041-9.
- 8.↲Ceia F, Fonseca C, Mota T, Morais H, Matias F, De Sousa A, Oliveira A. Prevalence of chronic heart failure in Southwestern Europe: the EPICA study. Eur J Heart Fail 2002;4:531-9.
- 9.↲Kelder JC, Cramer MJ, Van Wijngaarden J, Van Tooren R, Mosterd A, Moons KG, et al. The diagnostic value of physical examination and additional testing in primary care patients with suspected heart failure. Circulation 2011;124:2865-73.
- 10.↲Rutten FH, Moons KG, Cramer MJ, Grobbee DE, Zuithoff NP, Lammers JW, Hoes AW. Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study. BMJ 2005;331:1379.
- 11.↲Boonman-de Winter LJ, Rutten FH, Cramer MJ, Landman MJ, Zuithoff NP, Liem AH, Hoes AW. Efficiently screening heart failure in patients with type 2 diabetes. Eur J Heart Fail 2015;17:187-95.
- 12.↲Van Riet EE, Hoes AW, Limburg A, Landman MA, Kemperman H, Rutten FH. Extended prediction rule to optimize early detection of heart failure in older persons with non-acute shortness of breath: a cross-sectional study. BMJ Open 2016;15:6.
- 13.↲↲Hoes AW, Voors AA, Rutten FH, Van Lieshout J, Janssen PGH, Walma EP. NHG-Standaard Hartfalen. Huisarts Wet 2010;53:368-89.
- 14.↲Van Mourik Y, Rutten FH, Moons KG, Bertens LC, Hoes AW, Reitsma JB. Prevalence and underlying causes of dyspnoea in older people: a systematic review. Age Ageing 2014;43:319-26.
- 15.↲Masson S, Latini R, Anand IS, Barlera S, Angelici L, Vago T, et al. Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial). J Am Coll Cardiol 2008;52:997-1003.
- 16.↲Wong M, Staszewsky L, Latini R, Barlera S, Volpi A, Chiang YT, et al. Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study. J Am Coll Cardiol 2002;40:970-5.
- 17.↲Bongers FJ, Schellevis FG, Bakx C, Van den Bosch WJ, Van der Zee J. Treatment of heart failure in Dutch general practice. BMC Fam Pract 2006;7:40.
- 18.↲Bosch M, Wensing M, Bakx JC, Van der Weijden T, Hoes AW, Grol RP. Current treatment of chronic heart failure in primary care; still room for improvement. J Eval Clin Pract 2010;16:644-50.
- 19.↲Luttik ML, Jaarsma T, Van Geel PP, Brons M, Hillege HL, Hoes AW, et al. Long-term follow-up in optimally treated and stable heart failure patients: primary care vs. heart failure clinic. Results of the COACH-2 study. Eur J Heart Fail 2014;16:1241-8.
- 20.↲Schou M, Gustafsson F, Videbaek L, Tuxen C, Keller N, Handberg J, et al. Extended heart failure clinic follow-up in low-risk patients: a randomized clinical trial (NortStar). Eur Heart J 2013;34:432-42.
- 21.↲Van Riet EE, Hoes AW, Limburg A, Landman MA, Zuithoff PN, Rutten FH. Effect of training general practitioners in drug treatment of newly detected heart failure patients with reduced or preserved ejection fraction: a cluster randomized trial. Int J Cardiol 2016;217:174-82.
- 22.↲Lodewijks-Van de Bolt CL, Baur LH, Lenderink T, Guldemond F, Nijhof J, Winkens R, et al. The Dutch experience of open acces echocardiography. Neth Heart J 2007;15:342-7.
- 23.↲Sulaiman ND, Barton CA, Liaw ST, Harris CA, Sawyer SM, Abramson MJ, et al. Do small group workshops and locally adapted guidelines improve asthma patients’ health outcomes? A cluster randomized controlled trial. Fam Pract 2010;27:246-54.
- 24.↲Van Bruggen R, Gorter K, Stolk R, Klungel O, Rutten G. Clinical inertia in general practice: widespread and related to the outcome of diabetes care. Fam Pract 2009;26:428-36.
- 25.↲Byrnes PD. Why haven’t I changed that? Therapeutic inertia in general practice. Aust Fan Physician 2011;40;24-8.
Reacties
Er zijn nog geen reacties.